Topics of Presentation

• Review results of clinical program designed in consultation with FDA

  • Primary objectives
    • FLOVENT DISKUS:Greater efficacy compared to placebo with no significant safety concerns
    • ADVAIR DISKUS:Greater efficacy compared to fluticasone propionate (FP) and salmeterol alone with no significant safety concerns

• Review long-term safety data with FP

Previous slide

Next slide

Back to first slide

View graphic version